NCT01828112 2025-02-07
LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib
Novartis
Phase 3 Completed
Novartis
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
National Cancer Institute (NCI)